论文部分内容阅读
AIM: To investigate the behaviour of total plasma homocysteine (tHcy) and its most common genetic determinant defect, the methylenetetrahydrofolate reductase C677T (C677TMTHFR) polymorphism in patients with early stage colorectal carcinoma. METHODS: tHcy was quantified by Abbott IMx immunoassay; screening for C677TMTHFR substitution was performed by PCR and restriction analysis. RESULTS: The frequency of the C/T and T/T genotypes of the C677TMTHFR gene polymorphism did not differ between the groups. The mean tHcy was statistically higher in cancer patients than in control subjects carrying the same C/C or C/T genotype, whereas there was no difference in the T/T homozygous carriers of the two groups. tHcy was significantly higher in the T/T homozygous carriers than in C/C and C/T genotype carriers. CONCLUSION: The statistically significant increase of tHcy observed in C/C and C/T genotype carriers among our cancer patients is related to substrate consumption dependent on the tumor cell proliferation rate, whereas the tHcy increase observed in T/T genotype carriers of both groups probably depends on the enzymatic deficit of the homocysteine conversion to methionine and/or on the folate deficiency.
AIM: To investigate the behavior of total plasma homocysteine (tHcy) and its most common genetic determinant defect, the methylenetetrahydrofolate reductase C677T (C677TMTHFR) polymorphism in patients with early stage colorectal carcinoma. METHODS: tHcy was quantified by Abbott IMx immunoassay; screening for C677TMTHFR substitution was performed by PCR and restriction analysis. RESULTS: The frequency of the C / T and T / T genotypes of the C677TMTHFR gene polymorphism did not differ between the groups. The mean tHcy was flora higher in cancer patients than in control subjects carrying the same C / C or C / T genotype, there was no difference in the T / T homozygous carriers of the two groups. tHcy was significantly higher in the T / T homozygous carriers than in C / C and C / T genotype carriers. CONCLUSION: The statistically significant increase of tHcy observed in C / C and C / T genotype carriers among our cancer patients is related to substrate consumption dependent on the tumor cell proliferation rate, while the tHcy increase observed in T / T genotype carriers of both groups probably depends on the enzymatic deficit of the homocysteine conversion to methionine and / or on the folate deficiency.